Zeto, a Santa Clara, CA-based medical technology company, raised $31M in Series B funding.
The round was led by MindWorks Global (MWG).
The company intends to use the funds to expand its commercial and operational teams, drive further growth and strengthen ongoing research and development efforts.
Led by CEO and Founder Aswin Gunasekar, Zeto is a medical technology company which specializes in EEG brain monitoring and diagnostics in healthcare. Through its wearable devices, it makes brain monitoring accessible in diverse clinical settings, including the ICU, ED, hospitals, offices, and at home.
Zeto delivers nationwide monitoring and interpretation services by neurologists, along with AI-driven notifications for conditions such as seizures and epilepsy. Looking ahead, Zeto plans to expand its capabilities to detect and manage conditions like depression, stroke and traumatic brain injury. Zeto’s EEG systems, which received FDA clearances in 2018 and 2024, are currently commercially available in the United States.
